Characterization of the heterozygous glucokinase knockout mouse as a translational disease model for glucose control in type 2 diabetes

Por Baker, D J, Atkinson, A M, Wilkinson, G P, Coope, G J, Charles, A D, Leighton, B
Publicado em 2014

Chronic glucokinase activator treatment at clinically translatable exposures gives durable glucose lowering in two animal models of type 2 diabetes

Por Baker, D J, Wilkinson, G P, Atkinson, A M, Jones, H B, Coghlan, M, Charles, A D, Leighton, B
Publicado em 2014

Predictive blood glucose lowering efficacy by Glucokinase activators in high fat fed female Zucker rats

Por Coope, G J, Atkinson, A M, Allott, C, McKerrecher, D, Johnstone, C, Pike, K G, Holme, P C, Vertigan, H, Gill, D, Coghlan, M P, Leighton, B
Publicado em 2006